Sylvester Comprehensive Cancer Center, University of Miami | Strategic Alliance Partners

November 02, 2020

Brandon Mahal, MD, assistant professor of radiation oncology, assistant director of community outreach and engagement, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the prevalence of prostate cancer among African American men. 

October 30, 2020

Gina Z. D'Amato, MD, discusses the importance of multidisciplinary care in sarcoma.

October 23, 2020

Brandon Mahal, MD, discusses the potential role of race with regard to molecular disparities among men with prostate cancer.

October 21, 2020

Gina Z. D'Amato, MD, discusses the limitations of liquid biopsy in sarcoma.

October 09, 2020

Gina Z. D'Amato, MD, discusses the diminishing role of chemotherapy in sarcoma.

September 02, 2020

Kathleen Moore, MD, discusses the anticipated impact of the phase 3 MIRASOL trial with mirvetuximab soravtansine in patients with platinum-resistant, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer with a high folate receptor alpha expression.

August 19, 2020

Gina Z. D'Amato, MD, discusses the utility of next-generation sequencing in patients with stage I, II, or III sarcoma.

August 07, 2020

Jonathan C. Trent, MD, PhD, discusses the role of circulating tumor DNA in soft tissue sarcoma. 

May 27, 2020

Gilberto de Lima Lopes, MD, discusses the appropriate duration of immunotherapy in lung cancer, treatment-related adverse events, and remaining challenges faced in the space.

May 21, 2020

Gilberto De Lima Lopes, MD, discusses the rationale to stop immunotherapy after 2 years in patients with lung cancer.

May 20, 2020

Gilberto De Lima Lopes, MD, discusses the rationale to stop immunotherapy after 2 years in patients with lung cancer.

May 20, 2020

Brian M. Slomovitz, MD, explaines the need to determine optimal sequencing strategies in endometrial cancer.

May 20, 2020

Brian M. Slomovitz, MD, explaines the need to determine optimal sequencing strategies in endometrial cancer.

May 01, 2020

Jonathan C. Trent, MD, PhD, discusses research efforts in bone and soft tissue sarcomas.

April 29, 2020

Gina Z. D'Amato, MD, discusses the evolution of treatment in sarcoma, the use of next-generation sequencing, and predictive and prognostic biomarkers under investigation in the space.

April 28, 2020

Terrence J. Bradley, MD, discusses the utility of ruxolitinib (Jakafi) in myelofibrosis and polycythemia vera.

April 25, 2020

Terrence J. Bradley, MD, discusses the challenges of treating patients with myeloproliferative neoplasms.

April 24, 2020

Gilberto De Lima Lopes, MD, discusses how he navigates challenges caused by COVID-19 to continue to provide optimal care to his patients with cancer.

April 17, 2020

Terrence J. Bradley, MD, discusses the evolution of therapeutic strategies in myeloproliferative neoplasms.

April 11, 2020

Gina Z. D'Amato, MD, discusses the emerging role of next-generation sequencing in sarcoma.